Need Help?

Low-coverage whole-sequencing of metastasised colorectal cancer samples treated with bevazicumab

Low-coverage whole-genome sequencing (LC-WGS) was performed on tumor tissue, normal tissue and plasma samples collected from mCRC patients from the AC-ANGIOPREDICT Phase II trial (NCT01822444) and the University Medical Center Mannheim (UMM).

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD50000000176 Illumina HiSeq 4000 164
Publications Citations
Analysis of cell free DNA to predict outcome to bevacizumab therapy in colorectal cancer patients.
NPJ Genom Med 9: 2024 33
0